BCP
BSX icon

BSN Capital Partners’s Boston Scientific BSX Stock Holding History

BSN Capital Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60.1M Buy
629,000
+129,000
+26% +$10.3M 1.53% 11
2025
Q4 		$50.1M Buy
+500,000
New +$49M 2.36% 11

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BSN Capital Partners's BSX Position: Q1 2026 in Review

BSN Capital Partners increased its Boston Scientific (BSX) stake by 26% in Q1 2026, buying an estimated $10.3M and bringing the position to 629,000 shares worth $60.1M. The position accounts for 1.53% of the portfolio, ranked #11.

BSN Capital Partners first reported a position in BSX in Q4 2025 and has held it in 2 quarters since. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • BSN Capital Partners held 629,000 shares of Boston Scientific worth $60.1M as of Q1 2026.
  • BSN Capital Partners bought 129,000 Boston Scientific shares in Q1 2026, an estimated $10.3M.
  • Boston Scientific made up 1.53% of BSN Capital Partners's portfolio in Q1 2026, its #11 holding.
  • BSN Capital Partners first reported a position in Boston Scientific in Q4 2025 and has held it in 2 quarters since.
  • 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on BSN Capital Partners's 13F filing for Q1 2026, filed 27 Apr 2026.